The drug industry is facing one of the largest patent cliffs in recent history. Will that mean dealmaking at the annual J.P.

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

There was a continued ... more than $2 billion from the drug in 2018. Farxiga is in second place in the market with $1.54 billion in sales last year. Jardiance also has a fast-track designation ...

There were no standing ovations at EASD ... Novo has instead begun a head-to-head trial of the oral version of its drug against Jardiance, with results expected from March 2018.

Comparing Tyrzepatide and Semaglutide in the slimming drug market, with potential growth driven by increasing obesity rates worldwide. Explore more here.

Chicago-based Meitheal Pharmaceuticals, along with its Chinese parent, was busy in 2024, adding both biosimilar drugs and ...

More than two years after the passage of the Inflation Reduction Act (“IRA”) and the Centers for Medicare and Medicaid Services’ (“CMS’”) ...

GEN uncovers seven biopharma-related trends based on interviews with experts and other industry stakeholders, as well as ...

Johnson & Johnson said a combination of its lung cancer drugs Rybrevant and Lazcluze kept people alive for at least a year ...

If I want to stop taking tablets, are there drug-free ways to control an overactive bladder? The short answer is, yes. Caffeine and alcohol should be avoided, as these can irritate the bladder and ...

Research suggests there’s a connection between glycemic control and mental health conditions such as anxiety and depression. Plus, dealing with your condition day in and day out can lead to ...